TR200000875T2 - Osteoblast-spesifik mitojenler ve sözkonusu bileşikleri içeren ilaçlar. - Google Patents
Osteoblast-spesifik mitojenler ve sözkonusu bileşikleri içeren ilaçlar.Info
- Publication number
- TR200000875T2 TR200000875T2 TR2000/00875T TR200000875T TR200000875T2 TR 200000875 T2 TR200000875 T2 TR 200000875T2 TR 2000/00875 T TR2000/00875 T TR 2000/00875T TR 200000875 T TR200000875 T TR 200000875T TR 200000875 T2 TR200000875 T2 TR 200000875T2
- Authority
- TR
- Turkey
- Prior art keywords
- compounds
- question
- drugs containing
- specific mitogens
- containing osteoblast
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003226 mitogen Substances 0.000 title 1
- 210000000963 osteoblast Anatomy 0.000 title 1
- 208000018083 Bone metabolism disease Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Bulus, R =6-24 karbon atomuna sahip alkil, alkenil veya alkinil; n=0-12; X=oksijen veya NH oldugu formül (I)'in bilesiklerine; ve bunlarin, genel formül (I)'in bilesiklerini vermek üzere, canli organizmada metabolizmasi mümkün olan, fizyolojik açidan güvenli tuzlar, esterler, optik açidan aktif formlar, rasematlar ve türevlerine, bunlari hazirlama yöntemlerine ve sözkonusu bilesikleri içeren, kemik metabolizmasi bozukluklarinin tedavisinde kullanilan ilaçlara yöneliktir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97117124A EP0906759A1 (de) | 1997-10-02 | 1997-10-02 | Neue Osteoblastenspezifische Mitogene: Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200000875T2 true TR200000875T2 (tr) | 2000-11-21 |
Family
ID=8227430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/00875T TR200000875T2 (tr) | 1997-10-02 | 1998-09-30 | Osteoblast-spesifik mitojenler ve sözkonusu bileşikleri içeren ilaçlar. |
Country Status (16)
Country | Link |
---|---|
US (1) | US6197759B1 (tr) |
EP (2) | EP0906759A1 (tr) |
JP (2) | JP2001518511A (tr) |
KR (1) | KR100392207B1 (tr) |
CN (1) | CN1191070C (tr) |
AR (1) | AR013538A1 (tr) |
AT (1) | ATE232103T1 (tr) |
AU (1) | AU738479B2 (tr) |
BR (1) | BR9813020A (tr) |
CA (1) | CA2304821C (tr) |
DE (1) | DE69811253T2 (tr) |
DK (1) | DK1019062T3 (tr) |
ES (1) | ES2191350T3 (tr) |
TR (1) | TR200000875T2 (tr) |
WO (1) | WO1999017781A1 (tr) |
ZA (1) | ZA988952B (tr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050012221A (ko) * | 2001-11-12 | 2005-01-31 | 오노 야꾸힝 고교 가부시키가이샤 | 프로스타글란딘 유도체를 유효성분으로 하는 국소 투여용지속성 필름형 제제 |
US7384652B2 (en) | 2002-06-24 | 2008-06-10 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Complexed-acidic-phospholipid-collagen composites for bone induction |
KR100789323B1 (ko) * | 2005-07-20 | 2007-12-28 | 주식회사 엔지켐 | 글리세롤 유도체의 위치 선택적 제조방법 및 그 중간체 |
US20100266691A1 (en) * | 2009-04-15 | 2010-10-21 | Battelle Memorial Institute | Agents and Methods to Stimulate Bone Healing |
CN113842504B (zh) * | 2021-09-22 | 2022-12-09 | 苏州大学附属第二医院 | 一种用于骨再生的多功能电纺支架的制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4164560A (en) | 1977-01-05 | 1979-08-14 | Folkman Moses J | Systems for the controlled release of macromolecules |
PL151315B1 (pl) * | 1987-04-17 | 1990-08-31 | Sposób wytwarzania nowych związków powierzchniowo czynnych | |
US5645591A (en) | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
US5238965A (en) * | 1991-05-31 | 1993-08-24 | The Procter & Gamble Company | Methods of using lysophosphatidic acids for regulating skin wrinkles |
ATE142460T1 (de) | 1991-06-21 | 1996-09-15 | Genetics Inst | Osteogene proteine enthaltende arzneimittel |
US5300687A (en) * | 1991-07-18 | 1994-04-05 | Ortho Pharmaceutical Corporation | Trifluoromethylbenzylphosphonates useful in treating osteoporosis |
WO1993020859A1 (en) | 1992-04-20 | 1993-10-28 | Board Of Regents Of The University Of Washington | Sustained release compositions for delivery of growth factors |
CA2093836A1 (en) | 1992-04-24 | 1993-10-25 | Wayne Gombotz | Biodegradable tgf-.beta. delivery system for bone regeneration |
US5565439A (en) * | 1992-11-24 | 1996-10-15 | The Procter & Gamble Company | Methods of using lysophosphatidic acid for treating hyperproliferative conditions |
CA2119090A1 (en) | 1993-03-26 | 1994-09-27 | Wayne R. Gombotz | Compositions for controlled release of biologically active tgf-.beta. |
ATE169924T1 (de) * | 1993-05-18 | 1998-09-15 | Takeda Chemical Industries Ltd | Benzopyran-derivate und ihre verwendung |
ES2065855B1 (es) * | 1993-05-31 | 1995-09-01 | Menarini Lab | Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos. |
DE19544635A1 (de) | 1995-11-30 | 1997-06-05 | Boehringer Mannheim Gmbh | Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
1997
- 1997-10-02 EP EP97117124A patent/EP0906759A1/de not_active Withdrawn
-
1998
- 1998-09-30 ES ES98954302T patent/ES2191350T3/es not_active Expired - Lifetime
- 1998-09-30 DK DK98954302T patent/DK1019062T3/da active
- 1998-09-30 AT AT98954302T patent/ATE232103T1/de not_active IP Right Cessation
- 1998-09-30 BR BR9813020-0A patent/BR9813020A/pt not_active Application Discontinuation
- 1998-09-30 TR TR2000/00875T patent/TR200000875T2/tr unknown
- 1998-09-30 WO PCT/EP1998/006214 patent/WO1999017781A1/en active IP Right Grant
- 1998-09-30 JP JP2000514652A patent/JP2001518511A/ja active Pending
- 1998-09-30 KR KR10-2000-7003443A patent/KR100392207B1/ko not_active IP Right Cessation
- 1998-09-30 CA CA002304821A patent/CA2304821C/en not_active Expired - Fee Related
- 1998-09-30 EP EP98954302A patent/EP1019062B1/en not_active Expired - Lifetime
- 1998-09-30 DE DE69811253T patent/DE69811253T2/de not_active Expired - Fee Related
- 1998-09-30 CN CNB988094193A patent/CN1191070C/zh not_active Expired - Fee Related
- 1998-09-30 US US09/508,714 patent/US6197759B1/en not_active Expired - Lifetime
- 1998-09-30 AU AU11483/99A patent/AU738479B2/en not_active Ceased
- 1998-10-01 ZA ZA9808952A patent/ZA988952B/xx unknown
- 1998-10-02 AR ARP980104917A patent/AR013538A1/es unknown
-
2004
- 2004-03-22 JP JP2004082628A patent/JP2004217667A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR100392207B1 (ko) | 2003-07-23 |
CN1191070C (zh) | 2005-03-02 |
EP0906759A1 (de) | 1999-04-07 |
JP2001518511A (ja) | 2001-10-16 |
CA2304821A1 (en) | 1999-04-15 |
AR013538A1 (es) | 2000-12-27 |
BR9813020A (pt) | 2000-08-15 |
ZA988952B (en) | 2000-04-03 |
US6197759B1 (en) | 2001-03-06 |
DK1019062T3 (da) | 2003-05-26 |
AU738479B2 (en) | 2001-09-20 |
WO1999017781A1 (en) | 1999-04-15 |
DE69811253T2 (de) | 2003-12-04 |
KR20010030822A (ko) | 2001-04-16 |
AU1148399A (en) | 1999-04-27 |
ES2191350T3 (es) | 2003-09-01 |
EP1019062A1 (en) | 2000-07-19 |
ATE232103T1 (de) | 2003-02-15 |
DE69811253D1 (de) | 2003-03-13 |
CN1271289A (zh) | 2000-10-25 |
JP2004217667A (ja) | 2004-08-05 |
CA2304821C (en) | 2005-08-02 |
EP1019062B1 (en) | 2003-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20020815L (no) | Synergistisk kombinasjon | |
FI885569A (fi) | Vattenloesliga kamptothecinanaloger. | |
AUPR177300A0 (en) | Therapeutic methods | |
DK0430045T3 (da) | Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion | |
NO2011018I1 (no) | Eribulin og farmasøytisk akseptable salter derav | |
DE69722426D1 (de) | Isobutylgaba und dessen derivate zur schmerzbehandlung | |
TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
TW200614983A (en) | 5-substituted-2-phenylamino benzamides as MEK inhibitors | |
DE69229442D1 (de) | Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung | |
ATE507226T1 (de) | 1,3,4-oxadiazol-2-one als ppar-delta-modulatoren und deren verwendung | |
DE69707372D1 (de) | Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne | |
TR200000875T2 (tr) | Osteoblast-spesifik mitojenler ve sözkonusu bileşikleri içeren ilaçlar. | |
MX9306049A (es) | Dinucleotido de nicotinamida-ademina y fosfato de dinucleotido de nicotinamida-adenina como farmacos para tratar la enfermedad de alzheimer. | |
DK0528164T3 (da) | Anvendelse af xanthinderivater til fremstilling af et lægemiddel til behandling af sekundære nervecelleskader og funktionsforstyrrelser efter kranie-hjerne-traumer | |
PT783495E (pt) | Derivados de quinoxalina uteis em terapia | |
DE69812028D1 (de) | Creatine Derivate für Asthma | |
HU9400908D0 (en) | Pharmaceutical compositions for treatng skin disorders | |
HUP9801985A2 (hu) | Cisztinszármazékok alkalmazása restenózis gyógyítására használható gyógyszerkészítmények előállítására | |
TR199700921T1 (tr) | Insanlarda görülen herpes-virüs-8'in tedavisinde pensiklovir'in kullanilmasi. | |
NO881734D0 (no) | Tiadiazolguanidiner og fremgangsmaate for deres fremstilling. |